Managing Immuno-Oncology Toxicity: Top 10 Innovative Institutional Solutions
Author:
Affiliation:
1. University of Texas Southwestern Medical Center, Dallas, TX
2. Fox Chase Cancer Center, Philadelphia, PA
3. The Ohio State University Comprehensive Cancer Center, Columbus, OH
4. Massachusetts General Hospital, Boston, MA
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
General Medicine
Link
https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_100018
Reference9 articles.
1. Late-Onset Adrenal Insufficiency More Than 1 Year after Stopping Pembrolizumab
2. Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab
3. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
4. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
5. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing quality of life: integrating palliative care for patients with hand-foot syndrome in oncology practice;BMJ Supportive & Palliative Care;2024-02-01
2. Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer;Current Oncology;2023-08-23
3. The Feasibility, Acceptability, and Effectiveness of Electronic Patient-Reported Outcome Symptom Monitoring for Immune Checkpoint Inhibitor Toxicities: A Systematic Review;JCO Clinical Cancer Informatics;2023-06
4. Exploring the educational needs for severe immune-related adverse events of PD-1/PD-L1 inhibitors in advanced lung cancer: A single-center observational study;Asia-Pacific Journal of Oncology Nursing;2022-08
5. The impact of an immuno-oncology service at a regional cancer centre based in the north west of the UK;British Journal of Nursing;2022-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3